Your browser doesn't support javascript.
loading
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.
Saladores, P; Mürdter, T; Eccles, D; Chowbay, B; Zgheib, N K; Winter, S; Ganchev, B; Eccles, B; Gerty, S; Tfayli, A; Lim, J S L; Yap, Y S; Ng, R C H; Wong, N S; Dent, R; Habbal, M Z; Schaeffeler, E; Eichelbaum, M; Schroth, W; Schwab, M; Brauch, H.
Afiliación
  • Saladores P; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Mürdter T; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Eccles D; 1] Faculty of Medicine, Cancer Sciences Academic Unit and University of Southampton Clinical Trials Unit, University of Southampton, Southampton, UK [2] University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Chowbay B; 1] Clinical Pharmacology Laboratory, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore [2] Academic Medicine Research Institute, Office of Clinical Sciences, Duke-NUS Graduate Medical School Singapore, Singapore, Singapore
  • Zgheib NK; Faculty of Medicine, Department of Pharmacology and Toxicology, American University of Beirut, Beirut, Lebanon.
  • Winter S; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Ganchev B; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Eccles B; 1] Faculty of Medicine, Cancer Sciences Academic Unit and University of Southampton Clinical Trials Unit, University of Southampton, Southampton, UK [2] University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Gerty S; 1] Faculty of Medicine, Cancer Sciences Academic Unit and University of Southampton Clinical Trials Unit, University of Southampton, Southampton, UK [2] University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Tfayli A; Hematology-Oncology Division, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Lim JS; Clinical Pharmacology Laboratory, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Yap YS; Department of Medical Oncology, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Ng RC; Department of Medical Oncology, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Wong NS; Department of Medical Oncology, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Dent R; Department of Medical Oncology, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Habbal MZ; Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Schaeffeler E; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Eichelbaum M; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Schroth W; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany.
  • Schwab M; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brauch H; 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany [2] University of Tübingen, Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pharmacogenomics J ; 15(1): 84-94, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25091503
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Premenopausia / Antineoplásicos Hormonales / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Premenopausia / Antineoplásicos Hormonales / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania